Elsevier Inc.

SHERPA: Unknown

People

  1. D'Andrea-Carlino
    D'Andrea-Carlino
  2. Hudis
    Hudis
  3. Fornier
    Fornier
  4. Lake
    Lake
  5. Norton
    Norton
  6. Sugarman
    Sugarman
  7. Dang
    Dang
  8. Drullinsky
    Drullinsky
  9. Modi
    Modi
  10. Robson
    Robson

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  2. Behavioral Sciences Service (4)
  3. Biostatistics Service (4)
  4. Breast Medicine Service (4)
  5. Department of Medicine (4)
  6. Epidemiology and Biostatistics (4)
  7. Psychiatry and Behavioral Sciences, Department of (4)
  8. Solid Tumor Oncology Division (4)
  9. Survivorship Research (4)
  10. Gynecologic Medicine Service (3)
Search Within
  1. "Clinical Breast Cancer"
  2. "Behavioral Sciences Service"
Formats
  1. Journal Article (4)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  2. Behavioral Sciences Service (4)
  3. Biostatistics Service (4)
  4. Breast Medicine Service (4)
  5. Department of Medicine (4)
  6. Epidemiology and Biostatistics (4)

More Groups

People
  1. Clifford Hudis (4)
  2. Gabriella D'Andrea-Carlino (4)
  3. Teresa Gilewski (4)
  4. Diana Lake (3)
  5. Larry Norton (3)
  6. Monica Fornier (3)

More People

Years
  1. 2018 (1)
  2. 2014 (1)
  3. 2010 (1)
  4. 2008 (1)
Publications
  1. Clinical Breast Cancer (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of paclitaxel and dasatinib in metastatic breast cancer
    Journal Article

    Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with Metastatic breast cancer
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Lake, D.; Gilewski, T.; Robson, M.; Goldfarb, S.; Drullinsky, P.; Sugarman, S.; Wasserheit Leiblich, C.; Fasano, J.; more...
    Clinical Breast Cancer (2014)

    Fulltext@MSK | Save
  • Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer
    Journal Article

    Drullinsky, P.; Sugarman, S. M.; Fornier, M. N.; D'Andrea, G.; Gilewski, T.; Lake, D.; Traina, T.; Wasserheit-Lieblich, C.; Sklarin, N.; Atieh-Graham, D.; more...
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible
    Journal Article

    Dang, C.; D'Andrea, G.; Lake, D.; Sugarman, S.; Fornier, M.; Moynahan, M. E.; Gilewski, T.; Hurria, A.; Mills, N.; Troso-Sandoval, T.; more...
    Clinical Breast Cancer (2008)

    Fulltext@MSK | Save